FDA Investigator Olalere D Fasipe
Olalere D Fasipe has conducted inspections on 24 sites in 1 countries as of 09 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
09 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Olalere D Fasipe:
Akbar J Zaidi,
Andrew F Cohen,
Angela Mock,
Ashley Defilippis,
Ashley Polizzotto,
Bernardica T Sculac Stern,
Carrie E Jolly,
Casey L Hamblin,
Charisse K Green,
Christine I Shaw,
Cynthia A Harris, MD, RN,
Daniel S Fam,
Edouard Viard,
Elizabeth P Kinsella,
Ellen J Tave,
Erica B Brush,
George G Calafactor,
H Ljamilla Selby,
Hala L Selby,
Iris C Macinnes,
Isaac N Baah,
J Elkins,
Jane C Chen,
Janet B Abt,
Jd Young,
Jeffrey R Wooley,
Jeremy L Stukes,
Jocelyn C Turner,
Jodi M Gatica,
Joy P Matthias,
L Grant,
Leighton Kn Gai,
LTJG Matthew R Palo,
Marc R Dickens,
Marcia G Evans,
Margaret M Annes,
Maribeth G Niesen,
Marlo Ianm Alintanahin,
Meredith P Soehl, Investigator,
Michael R Dominick,
Morgan J Matthews,
Pauline N Logan,
Peter M Trunk,
Philip M Steele, PhD,
Raymond M Lam,
Robert E Moncayo,
Ronda Rloyd Jones,
Rose Ashley,
Roy Baby,
Sarah A Meehan,
Shreya Shah,
Stephen J Rabe,
William H Shackelford,
Yaw O Osei,
Young M Yoon,
Yuyan Liang
Olalere D Fasipe's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2022 | FDA 483 | Rockwell Medical - Form 483, 2022-07-25 |
January, 2023 | FDA 483 | Amcor Rigid Packaging USA, LLC - Form 483, 2023-01-12 |
March, 2023 | FDA 483 | G Surgical LLC - Form 483, 2023-03-01 |
October, 2023 | FDA 483 | Nelson Enviromental Technologies, Inc. - Form 483, 2023-10-10 |
October, 2023 | FDA 483 | Neuro Rehab VR - Form 483, 2023-10-27 |
September, 2022 | FDA 483 | Sea-Long Medical Systems, LLC - Form 483, 2022-09-08 |
March, 2022 | FDA 483 | USA Medical, LLC - Form 483, 2022-03-15 |
May, 2023 | FDA 483 | BTI Filtration - Form 483, 2023-05-11 |
March, 2023 | EIR | G Surgical LLC - EIR, 2023-03-01 |
July, 2023 | FDA 483 | Immuno-Mycologics, Inc - Form 483, 2023-07-14 |
January, 2024 | FDA 483 | AutoMedx, LLC - Form 483, 2024-01-19 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more